Pharmacy Podcast NetworkPharmacy Podcast Network

Evidence for SGLT2 Drugs for Heart Failure in Patients without Diabetes | GameChangers

View descriptionShare

Geoff Wall, PharmD & Jamie Pitlick, PharmD discussing SGLT2 inhibitors, also called gliflozins, are a class of medications that inhibit reabsorption of glucose in the kidney and therefore lower blood sugar.  Recently SGLTs, which are currently indicated for Type 2 diabetes, have been investigated and received FDA approval for Heart failure with reduced ejection fraction (HFrEF).  Listen in to this episode to discover more about how these drugs work in this (HFrEF) disease state.

This episode is accredited for CPE.  This episode is accredited for CPE.  For CE details and to claim credit click here:  https://bit.ly/2ApMvWw 

  • Facebook
  • Twitter
  • WhatsApp
  • Email
  • Download

In 2 playlist(s)

  1. Pharmacy Podcast Network

    1,437 clip(s)

  2. GameChangers |  CEimpact

    50 clip(s)

Pharmacy Podcast Network

The Pharmacy Podcast Network is ranked as the number one podcast in healthcare dedicated to the Busi 
Social links
Follow podcast
Recent clips
Browse 1,445 clip(s)